Weiss Asset Management’s SpringWorks Therapeutics SWTX Stock Holding History

Weiss Asset Management’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-75,969	Closed	-$3.57M	–	767
2025 Q2	$3.57M	Buy	75,969 +16,349	+27%	+$727K	0.04%	188
2025 Q1	$2.63M	Buy	+59,620	New	+$2.74M	0.05%	148
2019 Q4	–	Sell	-17,194	Closed	-$373K	–	379
2019 Q3	$373K	Buy	+17,194	New	+$406K	0.03%	132

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Weiss Asset Management's SWTX Position: Q3 2025 in Review

Weiss Asset Management sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 75,969 shares — an estimated $3.57M sold.

Weiss Asset Management first reported a position in SWTX in Q3 2019 and held it in 3 quarters. The position peaked at $3.57M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

Weiss Asset Management reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
Weiss Asset Management sold 75,969 SpringWorks Therapeutics shares in Q3 2025, an estimated $3.57M.
Weiss Asset Management first reported a position in SpringWorks Therapeutics in Q3 2019 and held it in 3 quarters.
Weiss Asset Management's SpringWorks Therapeutics position peaked at $3.57M in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on Weiss Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.